2. Signaling Pathways
  3. Protein Tyrosine Kinase/RTK
  4. VEGFR
  5. VEGFR Isoform
  6. VEGFR Ligand

VEGFR Ligand

VEGFR Ligand (1):

Cat. No. Product Name Effect Purity
  • HY-P991141
    Inlecitug
    		Ligand
    Inlecitug is a chimeric monoclonal antibody targeting human KDR (kinase insert domain receptor). Inlecitug specifically binds to KDR, blocking the binding of vascular endothelial growth factor (VEGF) to KDR and inhibiting angiogenesis, thus exerting antitumor activity. Inlecitug is promising for research of cancers.